📊 Score Breakdown
Offering Ability
100
Cash Runway
85
Float Risk
30
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
⛈️
Warning
High probability of dilution event
60%
💰 Capital Raise
73%
• Low cash runway: 6 months remaining
• Active shelf registration ($5000M, 60586% of market cap)
📉 Score Deterioration
50%
• Score rose 53 points recently (worsening)
• Score in HIGH risk zone (75/100)
🔄 Reverse Split
45%
• 50-day avg $1.48 approaching $1 threshold
• Only 6 months cash — financial pressure
💹 Market Data
Market Cap$8.25M
Shares Outstanding5.85M
Float3.62M
Cash$640.7K
DebtN/A
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↓ 4.4% shares (2025Q4 vs prior)
14 institutional holders · 382.3K shares
#1
Focus Partners Wealth
166.5K shares
#2
VANGUARD GROUP INC
44.0K shares
#3
GEODE CAPITAL MANAGEMENT, LLC
32.5K shares
+ 11 more holders Sign up free to view →
📉 Short Interest
Short Interest332.2K
Days to Cover2.0
% of Float9.2%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Jun 30, 2025
xbrl
XBRL CONVERTIBLE
Jun 30, 2022
8-K
8K EVENT
Apr 28, 2026
424B5
ATM
Apr 28, 2026
S-1
SHELF
Apr 20, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for AMST
📊 AMST FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 AMST Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.